Routine board refresh, no immediate trading signal. Monitor for any subsequent board composition changes or strategic shifts, but this filing alone does not warrant action.
VTGN drugs
VTGN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 18 $0.6702entry
- T+1 · 5mo ago −4.52%α −4.21% · $0.6399
- T+5 · 5mo ago −8.00%α −6.33% · $0.6166
- T+20 · 4mo ago −64.19%α −64.72% · $0.2400
- T+60 · 2mo ago −63.71%α −65.61% · $0.2432
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two board members, Margaret FitzPatrick and Dr. Joanne Curley, notified Vistagen they will not stand for re-election at the 2026 Annual Meeting. Both will continue serving until the end of their terms. This is a routine board transition with no C-suite departures or red flags.
Key Facts
- Margaret FitzPatrick notified on June 16, 2026 of decision not to stand for re-election.
- Dr. Joanne Curley notified on June 17, 2026 of decision not to stand for re-election.
- Both will continue as directors until the end of their terms at the 2026 Annual Meeting.
- No replacements named; no CEO/CFO departure or resignation language.
Financial Impact
No financial impact disclosed.
Risk Factors
- Potential loss of board expertise if replacements are not equally qualified.
- Minimal, no material risk to operations or strategy.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-043989 |
| Document: 0001628280-26-043989-index-headers.html | 0001628280-26-043989 |
| Document: 0001628280-26-043989-index.html | 0001628280-26-043989 |
| Document: 0001628280-26-043989.txt | 0001628280-26-043989 |
Track record
21 reports on VTGN
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +20.40% at T+5 after the Jun 11, 2026 report. 1 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $0.1843 Now $0.1800 −2.33% settles Nov 24
- Nov 13, 20263d ago Press Release Neutral 5/10 Entry $0.1805 Now $0.1800 −0.28% settles Nov 23
- Nov 9, 20267d ago 8-K Neutral 4/10 Entry $0.1844 to $0.1843 Now $0.1800 −2.39% ▼ −0.05% +1.64% vs SPY
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $0.1844 to $0.1843 Now $0.1800 −2.39% ▼ −0.05% +1.64% vs SPY
- Oct 30, 202617d ago 8-K Bearish 6/10 Entry $0.1675 to $0.1844 Now $0.1800 −7.46% ▼ −10.09% −10.01% vs SPY
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $0.2300 to $0.2000 Now $0.1800 −21.74% ▼ −13.04% −11.55% vs SPY
- Sep 25, 20267w ago 8-K Neutral 4/10 Entry $0.2700 to $0.2800 Now $0.1800 −33.33% ▲ +3.70% +3.93% vs SPY
- Sep 24, 20267w ago 8-K Neutral 4/10 Entry $0.2950 to $0.2826 Now $0.1800 −38.98% ▼ −4.20% −3.79% vs SPY
- Sep 24, 20267w ago Press Release Neutral 4/10 Entry $0.2950 to $0.2826 Now $0.1800 −38.98% ▼ −4.20% −3.79% vs SPY
- Aug 14, 202613w ago 8-K Bearish 6/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers